Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum

Authors: Marije C Behet, Lander Foquet, Geert-Jan van Gemert, Else M Bijker, Philip Meuleman, Geert Leroux-Roels, Cornelus C Hermsen, Anja Scholzen, Robert W Sauerwein

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

Long-lasting and sterile protective immunity against Plasmodium falciparum can be achieved by immunization of malaria-naive human volunteers under chloroquine prophylaxis with sporozoites delivered by mosquito bites (CPS-immunization). Protection is mediated by sporozoite/liver-stage immunity. In this study, the capacity of CPS-induced antibodies to interfere with sporozoite functionality and development was explored.

Methods

IgG was purified from plasma samples obtained before and after CPS-immunization from two separate clinical trials. The functionality of these antibodies was assessed in vitro in gliding and human hepatocyte traversal assays, and in vivo in a human liver-chimeric mouse model.

Results

Whereas pre-treatment of sporozoites with 2 mg/ml IgG in the majority of the volunteers did not have an effect on in vitro sporozoite gliding motility, CPS-induced IgG showed a distinct inhibitory effect in the sporozoite in vitro traversal assay. Pre-treatment of P. falciparum sporozoites with post-immunization IgG significantly inhibited sporozoite traversal through hepatocytes in 9/9 samples when using 10 and 1 mg/ml IgG, and was dose-dependent, resulting in an average 16% and 37% reduction with 1 mg/ml IgG (p = 0.003) and 10 mg/ml IgG (p = 0.002), respectively. In vivo, CPS-induced IgG reduced liver-stage infection and/or development after a mosquito infection in the human liver-chimeric mouse model by 91.05% when comparing 11 mice receiving post-immunization IgG to 11 mice receiving pre-immunization IgG (p = 0.0008).

Conclusions

It is demonstrated for the first time that CPS-immunization induces functional antibodies against P. falciparum sporozoites, which are able to reduce parasite-host cell interaction by inhibiting parasite traversal and liver-stage infection. These data highlight the functional contribution of antibody responses to pre-erythrocytic immunity after whole-parasite immunization against P. falciparum malaria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stewart MJ, Vanderberg JP: Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool. 1988, 35: 389-393. 10.1111/j.1550-7408.1988.tb04115.x.CrossRefPubMed Stewart MJ, Vanderberg JP: Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool. 1988, 35: 389-393. 10.1111/j.1550-7408.1988.tb04115.x.CrossRefPubMed
2.
go back to reference Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodriguez A: Migration of Plasmodium sporozoites through cells before infection. Science. 2001, 291: 141-144. 10.1126/science.291.5501.141.CrossRefPubMed Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodriguez A: Migration of Plasmodium sporozoites through cells before infection. Science. 2001, 291: 141-144. 10.1126/science.291.5501.141.CrossRefPubMed
3.
go back to reference Amino R, Giovannini D, Thiberge S, Gueirard P, Boisson B, Dubremetz JF, Prevost MC, Ishino T, Yuda M, Menard R: Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe. 2008, 3: 88-96. 10.1016/j.chom.2007.12.007.CrossRefPubMed Amino R, Giovannini D, Thiberge S, Gueirard P, Boisson B, Dubremetz JF, Prevost MC, Ishino T, Yuda M, Menard R: Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe. 2008, 3: 88-96. 10.1016/j.chom.2007.12.007.CrossRefPubMed
4.
go back to reference Stewart MJ, Nawrot RJ, Schulman S, Vanderberg JP: Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies. Infect Immun. 1986, 51: 859-864.PubMedCentralPubMed Stewart MJ, Nawrot RJ, Schulman S, Vanderberg JP: Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies. Infect Immun. 1986, 51: 859-864.PubMedCentralPubMed
5.
go back to reference Sibley LD: Intracellular parasite invasion strategies. Science. 2004, 304: 248-253. 10.1126/science.1094717.CrossRefPubMed Sibley LD: Intracellular parasite invasion strategies. Science. 2004, 304: 248-253. 10.1126/science.1094717.CrossRefPubMed
6.
go back to reference Ishino T, Yano K, Chinzei Y, Yuda M: Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2004, 2: E4-10.1371/journal.pbio.0020004.PubMedCentralCrossRefPubMed Ishino T, Yano K, Chinzei Y, Yuda M: Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2004, 2: E4-10.1371/journal.pbio.0020004.PubMedCentralCrossRefPubMed
7.
go back to reference Tavares J, Formaglio P, Thiberge S, Mordelet E, Van Rooijen N, Medvinsky A, Menard R, Amino R: Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med. 2013, 210: 905-915. 10.1084/jem.20121130.PubMedCentralCrossRefPubMed Tavares J, Formaglio P, Thiberge S, Mordelet E, Van Rooijen N, Medvinsky A, Menard R, Amino R: Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med. 2013, 210: 905-915. 10.1084/jem.20121130.PubMedCentralCrossRefPubMed
8.
go back to reference Menard R, Tavares J, Cockburn I, Markus M, Zavala F, Amino R: Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol. 2013, 11: 701-712. 10.1038/nrmicro3111.CrossRefPubMed Menard R, Tavares J, Cockburn I, Markus M, Zavala F, Amino R: Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol. 2013, 11: 701-712. 10.1038/nrmicro3111.CrossRefPubMed
9.
go back to reference Prudencio M, Rodriguez A, Mota MM: The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol. 2006, 4: 849-856. 10.1038/nrmicro1529.CrossRefPubMed Prudencio M, Rodriguez A, Mota MM: The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol. 2006, 4: 849-856. 10.1038/nrmicro1529.CrossRefPubMed
11.
go back to reference Cohen S, McGregor IA, Carrington S: Gamma-globulin and acquired immunity to human malaria. Nature. 1961, 192: 733-737. 10.1038/192733a0.CrossRefPubMed Cohen S, McGregor IA, Carrington S: Gamma-globulin and acquired immunity to human malaria. Nature. 1961, 192: 733-737. 10.1038/192733a0.CrossRefPubMed
12.
go back to reference McGregor IA, Carrington SP, Cohen S: Treatment of East African P. falciparum malaria with West African human gamma-globulin. Trans R Soc Trop Med Hyg. 1963, 57: 170-175. 10.1016/0035-9203(63)90058-0.CrossRef McGregor IA, Carrington SP, Cohen S: Treatment of East African P. falciparum malaria with West African human gamma-globulin. Trans R Soc Trop Med Hyg. 1963, 57: 170-175. 10.1016/0035-9203(63)90058-0.CrossRef
13.
go back to reference Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P: Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991, 45: 297-308.PubMed Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P: Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991, 45: 297-308.PubMed
14.
15.
go back to reference Bruce-Chwatt LJ, Gibson FD: Transplacental passage of Plasmodium berghei and passive transfer of immunity in rats and mice. Trans R Soc Trop Med Hyg. 1956, 50: 47-53. 10.1016/0035-9203(56)90007-4.CrossRefPubMed Bruce-Chwatt LJ, Gibson FD: Transplacental passage of Plasmodium berghei and passive transfer of immunity in rats and mice. Trans R Soc Trop Med Hyg. 1956, 50: 47-53. 10.1016/0035-9203(56)90007-4.CrossRefPubMed
16.
go back to reference Diggs CL, Osler AG: Humoral immunity in rodent malaria. II. Inhibition of parasitemia by serum antibody. J Immunol. 1969, 102: 298-305.PubMed Diggs CL, Osler AG: Humoral immunity in rodent malaria. II. Inhibition of parasitemia by serum antibody. J Immunol. 1969, 102: 298-305.PubMed
17.
go back to reference Nussenzweig RS, Nussenzweig V: Development of sporozoite vaccines. Philos Trans R Soc Lond B Biol Sci. 1984, 307: 117-128. 10.1098/rstb.1984.0113.CrossRefPubMed Nussenzweig RS, Nussenzweig V: Development of sporozoite vaccines. Philos Trans R Soc Lond B Biol Sci. 1984, 307: 117-128. 10.1098/rstb.1984.0113.CrossRefPubMed
18.
go back to reference Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. N Engl J Med. 1997, 336: 86-91. 10.1056/NEJM199701093360202.CrossRefPubMed Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. N Engl J Med. 1997, 336: 86-91. 10.1056/NEJM199701093360202.CrossRefPubMed
19.
go back to reference Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Wellde BT, White K, Sun P, Schwenk R, Krzych U, Delchambre M, Voss G, Dubois MC, Gasser RA, Dowler MG, O'Brien M, Wittes J, Wirtz R, Cohen J, Ballou WR: Rts SMVEG: A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS, S/AS02A in malaria-naive adults. Vaccine. 2007, 25: 5359-5366. 10.1016/j.vaccine.2007.05.005.CrossRefPubMed Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Wellde BT, White K, Sun P, Schwenk R, Krzych U, Delchambre M, Voss G, Dubois MC, Gasser RA, Dowler MG, O'Brien M, Wittes J, Wirtz R, Cohen J, Ballou WR: Rts SMVEG: A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS, S/AS02A in malaria-naive adults. Vaccine. 2007, 25: 5359-5366. 10.1016/j.vaccine.2007.05.005.CrossRefPubMed
20.
go back to reference Kester KE, Cummings JF, Ockenhouse CF, Nielsen R, Hall BT, Gordon DM, Schwenk RJ, Krzych U, Holland CA, Richmond G, Dowler MG, Williams J, Wirtz RA, Tornieporth N, Vigneron L, Delchambre M, Demoitie MA, Ballou WR, Cohen J, Heppner DG: Rts SMVEG: Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS, S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine. 2008, 26: 2191-2202. 10.1016/j.vaccine.2008.02.048.CrossRefPubMed Kester KE, Cummings JF, Ockenhouse CF, Nielsen R, Hall BT, Gordon DM, Schwenk RJ, Krzych U, Holland CA, Richmond G, Dowler MG, Williams J, Wirtz RA, Tornieporth N, Vigneron L, Delchambre M, Demoitie MA, Ballou WR, Cohen J, Heppner DG: Rts SMVEG: Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS, S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine. 2008, 26: 2191-2202. 10.1016/j.vaccine.2008.02.048.CrossRefPubMed
21.
go back to reference Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG, Rts SVEG: Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis. 2009, 200: 337-346. 10.1086/600120.CrossRefPubMed Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG, Rts SVEG: Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis. 2009, 200: 337-346. 10.1086/600120.CrossRefPubMed
22.
go back to reference Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K, Glenn G, Ockenhouse CF, Garcon N, Schwenk R, Lanar DE, Sun P, Momin P, Wirtz RA, Golenda C, Slaoui M, Wortmann G, Holland C, Dowler M, Cohen J, Ballou WR: Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccine. J Infect Dis. 1998, 178: 1139-1144. 10.1086/515657.CrossRefPubMed Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K, Glenn G, Ockenhouse CF, Garcon N, Schwenk R, Lanar DE, Sun P, Momin P, Wirtz RA, Golenda C, Slaoui M, Wortmann G, Holland C, Dowler M, Cohen J, Ballou WR: Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccine. J Infect Dis. 1998, 178: 1139-1144. 10.1086/515657.CrossRefPubMed
23.
go back to reference Casares S, Brumeanu TD, Richie TL: The RTS, S malaria vaccine. Vaccine. 2010, 28: 4880-4894. 10.1016/j.vaccine.2010.05.033.CrossRefPubMed Casares S, Brumeanu TD, Richie TL: The RTS, S malaria vaccine. Vaccine. 2010, 28: 4880-4894. 10.1016/j.vaccine.2010.05.033.CrossRefPubMed
24.
go back to reference Rts SCTP, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Machevo S, Acacio S, Bulo H, Sigauque B, Macete E, Alonso P, Abdulla S, Salim N, Minja R, Mpina M, Ahmed S, Ali AM, Mtoro AT, Hamad AS, Mutani P: A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med. 2012, 367: 2284-2295.CrossRef Rts SCTP, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Machevo S, Acacio S, Bulo H, Sigauque B, Macete E, Alonso P, Abdulla S, Salim N, Minja R, Mpina M, Ahmed S, Ali AM, Mtoro AT, Hamad AS, Mutani P: A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med. 2012, 367: 2284-2295.CrossRef
25.
go back to reference White MT, Bejon P, Olotu A, Griffin JT, Riley EM, Kester KE, Ockenhouse CF, Ghani AC: The relationship between RTS, S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection. PLoS One. 2013, 8: e61395-10.1371/journal.pone.0061395.PubMedCentralCrossRefPubMed White MT, Bejon P, Olotu A, Griffin JT, Riley EM, Kester KE, Ockenhouse CF, Ghani AC: The relationship between RTS, S vaccine-induced antibodies, CD4(+) T cell responses and protection against Plasmodium falciparum infection. PLoS One. 2013, 8: e61395-10.1371/journal.pone.0061395.PubMedCentralCrossRefPubMed
26.
go back to reference Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, Lievens M, Leboulleux D, Njuguna P, Peshu N, Marsh K, Bejon P: Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N Engl J Med. 2013, 368: 1111-1120. 10.1056/NEJMoa1207564.CrossRefPubMed Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, Leach A, Lievens M, Leboulleux D, Njuguna P, Peshu N, Marsh K, Bejon P: Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N Engl J Med. 2013, 368: 1111-1120. 10.1056/NEJMoa1207564.CrossRefPubMed
27.
go back to reference Cowan G, Krishna S, Crisanti A, Robson K: Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet. 1992, 339: 1412-1413. 10.1016/0140-6736(92)91229-2.CrossRefPubMed Cowan G, Krishna S, Crisanti A, Robson K: Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet. 1992, 339: 1412-1413. 10.1016/0140-6736(92)91229-2.CrossRefPubMed
28.
go back to reference Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, Gordon DM, Nussler AK, Aikawa M, Hoffman SL: Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A. 1992, 89: 9176-9180. 10.1073/pnas.89.19.9176.PubMedCentralCrossRefPubMed Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, Gordon DM, Nussler AK, Aikawa M, Hoffman SL: Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A. 1992, 89: 9176-9180. 10.1073/pnas.89.19.9176.PubMedCentralCrossRefPubMed
29.
go back to reference Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL: Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science. 1991, 252: 715-718. 10.1126/science.1827210.CrossRefPubMed Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL: Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science. 1991, 252: 715-718. 10.1126/science.1827210.CrossRefPubMed
30.
go back to reference Walsh DS, Pichyangkul S, Gettayacamin M, Tongtawe P, Siegrist CA, Hansukjariya P, Kester KE, Holland CA, Voss G, Cohen J, Stewart AV, Miller RS, Ballou WR, Heppner DG: Safety and immunogenicity of rts, s + trap malaria vaccine, formulated in the AS02A adjuvant system, in infant rhesus monkeys. Am J Trop Med Hyg. 2004, 70: 499-509.PubMed Walsh DS, Pichyangkul S, Gettayacamin M, Tongtawe P, Siegrist CA, Hansukjariya P, Kester KE, Holland CA, Voss G, Cohen J, Stewart AV, Miller RS, Ballou WR, Heppner DG: Safety and immunogenicity of rts, s + trap malaria vaccine, formulated in the AS02A adjuvant system, in infant rhesus monkeys. Am J Trop Med Hyg. 2004, 70: 499-509.PubMed
31.
go back to reference Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG: Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine. 2010, 28: 5135-5144. 10.1016/j.vaccine.2009.08.046.CrossRefPubMed Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG: Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine. 2010, 28: 5135-5144. 10.1016/j.vaccine.2009.08.046.CrossRefPubMed
32.
go back to reference Nussenzweig RS, Vanderberg J, Most H, Orton C: Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature. 1967, 216: 160-162. 10.1038/216160a0.CrossRefPubMed Nussenzweig RS, Vanderberg J, Most H, Orton C: Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature. 1967, 216: 160-162. 10.1038/216160a0.CrossRefPubMed
33.
go back to reference Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS: Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ. 1979, 57 (Suppl 1): 165-173.PubMedCentralPubMed Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS: Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ. 1979, 57 (Suppl 1): 165-173.PubMedCentralPubMed
34.
go back to reference Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LW, Sedegah M, Heppner DG, Ballou WR, Richie TL: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002, 185: 1155-1164. 10.1086/339409.CrossRefPubMed Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LW, Sedegah M, Heppner DG, Ballou WR, Richie TL: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002, 185: 1155-1164. 10.1086/339409.CrossRefPubMed
35.
go back to reference Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V: Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987, 330: 664-666. 10.1038/330664a0.CrossRefPubMed Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V: Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987, 330: 664-666. 10.1038/330664a0.CrossRefPubMed
36.
go back to reference Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW: Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization. Parasite Immunol. 2012, 34: 562-569. 10.1111/pim.12000.x.CrossRefPubMed Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW: Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization. Parasite Immunol. 2012, 34: 562-569. 10.1111/pim.12000.x.CrossRefPubMed
37.
go back to reference Hollingdale MR, Nardin EH, Tharavanij S, Schwartz AL, Nussenzweig RS: Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J Immunol. 1984, 132: 909-913.PubMed Hollingdale MR, Nardin EH, Tharavanij S, Schwartz AL, Nussenzweig RS: Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J Immunol. 1984, 132: 909-913.PubMed
38.
go back to reference Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, Hollingdale MR, Ballou WR, Gordon DM: Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 1993, 49: 166-173.PubMed Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, Hollingdale MR, Ballou WR, Gordon DM: Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 1993, 49: 166-173.PubMed
39.
go back to reference Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, Losonsky G, Hollingdale M, Sztein M, Levine M, Nussenzweig R, Clyde DF, Edelman R: Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg. 1991, 45: 539-547.PubMed Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, Losonsky G, Hollingdale M, Sztein M, Levine M, Nussenzweig R, Clyde DF, Edelman R: Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg. 1991, 45: 539-547.PubMed
40.
go back to reference Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL: Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013, 341: 1359-1365. 10.1126/science.1241800.CrossRefPubMed Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL: Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013, 341: 1359-1365. 10.1126/science.1241800.CrossRefPubMed
41.
go back to reference Sack BK, Miller JL, Vaughan AM, Douglass A, Kaushansky A, Mikolajczak S, Coppi A, Gonzalez-Aseguinolaza G, Tsuji M, Zavala F, Sinnis P, Kappe SH: Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun. 2014, 82: 808-817. 10.1128/IAI.01249-13.PubMedCentralCrossRefPubMed Sack BK, Miller JL, Vaughan AM, Douglass A, Kaushansky A, Mikolajczak S, Coppi A, Gonzalez-Aseguinolaza G, Tsuji M, Zavala F, Sinnis P, Kappe SH: Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun. 2014, 82: 808-817. 10.1128/IAI.01249-13.PubMedCentralCrossRefPubMed
42.
go back to reference Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH: First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine. 2013, 31: 4975-4983. 10.1016/j.vaccine.2013.08.007.CrossRefPubMed Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH: First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine. 2013, 31: 4975-4983. 10.1016/j.vaccine.2013.08.007.CrossRefPubMed
43.
go back to reference Finney OC, Keitany GJ, Smithers H, Kappe S, Wang R: Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Vaccine. 2014, doi: 10.1016/j.vaccine.2014.02.055. [Epub ahead of print] Finney OC, Keitany GJ, Smithers H, Kappe S, Wang R: Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Vaccine. 2014, doi: 10.1016/j.vaccine.2014.02.055. [Epub ahead of print]
44.
go back to reference Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, Van Gemert GJ, van de Vegte-Bolmer M, Van Schaijk B, Teelen K, Arens T, Spaarman L, De Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein R: Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009, 361: 468-477. 10.1056/NEJMoa0805832.CrossRefPubMed Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, Van Gemert GJ, van de Vegte-Bolmer M, Van Schaijk B, Teelen K, Arens T, Spaarman L, De Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein R: Protection against a malaria challenge by sporozoite inoculation. N Engl J Med. 2009, 361: 468-477. 10.1056/NEJMoa0805832.CrossRefPubMed
45.
go back to reference Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, Van Gemert G, van de Vegte-Bolmer M, van der Ven AJ, Luty AJ, Hermsen CC, Sauerwein RW: Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet. 2011, 377: 1770-1776. 10.1016/S0140-6736(11)60360-7.CrossRefPubMed Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, Van Gemert G, van de Vegte-Bolmer M, van der Ven AJ, Luty AJ, Hermsen CC, Sauerwein RW: Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet. 2011, 377: 1770-1776. 10.1016/S0140-6736(11)60360-7.CrossRefPubMed
46.
go back to reference Bijker EM, Bastiaens GJ, Teirlinck AC, Van Gemert GJ, Graumans W, van de Vegte-Bolmer M, Siebelink-Stoter R, Arens T, Teelen K, Nahrendorf W, Remarque EJ, Roeffen W, Jansens A, Zimmerman D, Vos M, Van Schaijk BC, Wiersma J, van der Ven AJ, De Mast Q, Van Lieshout L, Verweij JJ, Hermsen CC, Scholzen A, Sauerwein RW: Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci U S A. 2013, 110: 7862-7867. 10.1073/pnas.1220360110.PubMedCentralCrossRefPubMed Bijker EM, Bastiaens GJ, Teirlinck AC, Van Gemert GJ, Graumans W, van de Vegte-Bolmer M, Siebelink-Stoter R, Arens T, Teelen K, Nahrendorf W, Remarque EJ, Roeffen W, Jansens A, Zimmerman D, Vos M, Van Schaijk BC, Wiersma J, van der Ven AJ, De Mast Q, Van Lieshout L, Verweij JJ, Hermsen CC, Scholzen A, Sauerwein RW: Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci U S A. 2013, 110: 7862-7867. 10.1073/pnas.1220360110.PubMedCentralCrossRefPubMed
47.
go back to reference Teirlinck AC, McCall MB, Roestenberg M, Scholzen A, Woestenenk R, De Mast Q, van der Ven AJ, Hermsen CC, Luty AJ, Sauerwein RW: Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011, 7: e1002389-10.1371/journal.ppat.1002389.PubMedCentralCrossRefPubMed Teirlinck AC, McCall MB, Roestenberg M, Scholzen A, Woestenenk R, De Mast Q, van der Ven AJ, Hermsen CC, Luty AJ, Sauerwein RW: Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011, 7: e1002389-10.1371/journal.ppat.1002389.PubMedCentralCrossRefPubMed
48.
go back to reference Felgner PL, Roestenberg M, Liang L, Hung C, Jain A, Pablo J, Nakajima-Sasaki R, Molina D, Teelen K, Hermsen CC, Sauerwein R: Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep. 2013, 3: 3549-CrossRefPubMed Felgner PL, Roestenberg M, Liang L, Hung C, Jain A, Pablo J, Nakajima-Sasaki R, Molina D, Teelen K, Hermsen CC, Sauerwein R: Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep. 2013, 3: 3549-CrossRefPubMed
49.
go back to reference Ifediba T, Vanderberg JP: Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature. 1981, 294: 364-366. 10.1038/294364a0.CrossRefPubMed Ifediba T, Vanderberg JP: Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature. 1981, 294: 364-366. 10.1038/294364a0.CrossRefPubMed
50.
go back to reference Ponnudurai T, Lensen AH, Leeuwenberg AD, Meuwissen JH: Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. Trans R Soc Trop Med Hyg. 1982, 76: 812-818. 10.1016/0035-9203(82)90116-X.CrossRefPubMed Ponnudurai T, Lensen AH, Leeuwenberg AD, Meuwissen JH: Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. Trans R Soc Trop Med Hyg. 1982, 76: 812-818. 10.1016/0035-9203(82)90116-X.CrossRefPubMed
51.
go back to reference Ponnudurai T, Lensen AH, Meis JF, Meuwissen JH: Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology. 1986, 93 (Pt 2): 263-274.CrossRefPubMed Ponnudurai T, Lensen AH, Meis JF, Meuwissen JH: Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology. 1986, 93 (Pt 2): 263-274.CrossRefPubMed
52.
go back to reference Ponnudurai T, Lensen AH, Van Gemert GJ, Bensink MP, Bolmer M, Meuwissen JH: Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology. 1989, 98 (Pt 2): 165-173.CrossRefPubMed Ponnudurai T, Lensen AH, Van Gemert GJ, Bensink MP, Bolmer M, Meuwissen JH: Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology. 1989, 98 (Pt 2): 165-173.CrossRefPubMed
53.
go back to reference Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y: Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med. 1982, 156: 20-30. 10.1084/jem.156.1.20.CrossRefPubMed Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y: Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med. 1982, 156: 20-30. 10.1084/jem.156.1.20.CrossRefPubMed
54.
go back to reference Prudencio M, Rodrigues CD, Ataide R, Mota MM: Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell Microbiol. 2008, 10: 218-224.PubMed Prudencio M, Rodrigues CD, Ataide R, Mota MM: Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell Microbiol. 2008, 10: 218-224.PubMed
55.
go back to reference Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, Coleman RE, Udomsangpetch R, Cui L, Brewer TG: Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg. 2006, 74: 708-715.PubMed Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, Coleman RE, Udomsangpetch R, Cui L, Brewer TG: Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg. 2006, 74: 708-715.PubMed
56.
go back to reference Sampath P, Pollard TD: Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry. 1991, 30: 1973-1980. 10.1021/bi00221a034.CrossRefPubMed Sampath P, Pollard TD: Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry. 1991, 30: 1973-1980. 10.1021/bi00221a034.CrossRefPubMed
57.
go back to reference Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, Roskams T, Leroux-Roels G: Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology. 2005, 41: 847-856. 10.1002/hep.20657.CrossRefPubMed Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, Vandekerckhove J, Roskams T, Leroux-Roels G: Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology. 2005, 41: 847-856. 10.1002/hep.20657.CrossRefPubMed
58.
go back to reference Foquet L, Hermsen CC, Van Gemert GJ, Libbrecht L, Sauerwein R, Meuleman P, Leroux-Roels G: Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice. Malar J. 2013, 12: 430-10.1186/1475-2875-12-430.PubMedCentralCrossRefPubMed Foquet L, Hermsen CC, Van Gemert GJ, Libbrecht L, Sauerwein R, Meuleman P, Leroux-Roels G: Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice. Malar J. 2013, 12: 430-10.1186/1475-2875-12-430.PubMedCentralCrossRefPubMed
59.
go back to reference Leitner WW, Bergmann-Leitner ES, Angov E: Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Malar J. 2010, 9: 145-10.1186/1475-2875-9-145.PubMedCentralCrossRefPubMed Leitner WW, Bergmann-Leitner ES, Angov E: Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Malar J. 2010, 9: 145-10.1186/1475-2875-9-145.PubMedCentralCrossRefPubMed
60.
go back to reference Yoeli M, Upmanis RS, Vanderberg J, Most H: Life cycle and patterns of development of Plasmodium berghei in normal and experimental hosts. Mil Med. 1966, 131 (Suppl): 900-914.PubMed Yoeli M, Upmanis RS, Vanderberg J, Most H: Life cycle and patterns of development of Plasmodium berghei in normal and experimental hosts. Mil Med. 1966, 131 (Suppl): 900-914.PubMed
61.
go back to reference Foquet L, Hermsen CC, Van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, Meuleman P, Leroux-Roels G: Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest. 2013, 124: 140-144.PubMedCentralCrossRef Foquet L, Hermsen CC, Van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, Meuleman P, Leroux-Roels G: Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection. J Clin Invest. 2013, 124: 140-144.PubMedCentralCrossRef
62.
go back to reference Hermsen CC, Telgt DS, Linders EH, van de Locht LA, Eling WM, Mensink EJ, Sauerwein RW: Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol. 2001, 118: 247-251. 10.1016/S0166-6851(01)00379-6.CrossRefPubMed Hermsen CC, Telgt DS, Linders EH, van de Locht LA, Eling WM, Mensink EJ, Sauerwein RW: Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol. 2001, 118: 247-251. 10.1016/S0166-6851(01)00379-6.CrossRefPubMed
63.
go back to reference Alcoser SY, Kimmel DJ, Borgel SD, Carter JP, Dougherty KM, Hollingshead MG: Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC Biotechnol. 2011, 11: 124-10.1186/1472-6750-11-124.PubMedCentralCrossRefPubMed Alcoser SY, Kimmel DJ, Borgel SD, Carter JP, Dougherty KM, Hollingshead MG: Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC Biotechnol. 2011, 11: 124-10.1186/1472-6750-11-124.PubMedCentralCrossRefPubMed
64.
go back to reference Vanderberg JP, Frevert U: Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int J Parasitol. 2004, 34: 991-996. 10.1016/j.ijpara.2004.05.005.CrossRefPubMed Vanderberg JP, Frevert U: Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int J Parasitol. 2004, 34: 991-996. 10.1016/j.ijpara.2004.05.005.CrossRefPubMed
65.
go back to reference Vanderberg J, Mueller AK, Heiss K, Goetz K, Matuschewski K, Deckert M, Schluter D: Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. Am J Pathol. 2007, 171: 1405-1406. 10.2353/ajpath.2007.070661. author reply 1406CrossRefPubMed Vanderberg J, Mueller AK, Heiss K, Goetz K, Matuschewski K, Deckert M, Schluter D: Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. Am J Pathol. 2007, 171: 1405-1406. 10.2353/ajpath.2007.070661. author reply 1406CrossRefPubMed
66.
go back to reference Kebaier C, Voza T, Vanderberg J: Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice. PLoS Pathog. 2009, 5: e1000399-10.1371/journal.ppat.1000399.PubMedCentralCrossRefPubMed Kebaier C, Voza T, Vanderberg J: Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice. PLoS Pathog. 2009, 5: e1000399-10.1371/journal.ppat.1000399.PubMedCentralCrossRefPubMed
67.
go back to reference Kaushansky A, Rezakhani N, Mann H, Kappe SH: Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites. Mol Biochem Parasitol. 2012, 183: 100-103. 10.1016/j.molbiopara.2012.01.006.PubMedCentralCrossRefPubMed Kaushansky A, Rezakhani N, Mann H, Kappe SH: Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites. Mol Biochem Parasitol. 2012, 183: 100-103. 10.1016/j.molbiopara.2012.01.006.PubMedCentralCrossRefPubMed
68.
go back to reference Van Dijk MR, Douradinha B, Franke-Fayard B, Heussler V, Van Dooren MW, Van Schaijk B, Van Gemert GJ, Sauerwein RW, Mota MM, Waters AP, Janse CJ: Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A. 2005, 102: 12194-12199. 10.1073/pnas.0500925102.PubMedCentralCrossRefPubMed Van Dijk MR, Douradinha B, Franke-Fayard B, Heussler V, Van Dooren MW, Van Schaijk B, Van Gemert GJ, Sauerwein RW, Mota MM, Waters AP, Janse CJ: Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A. 2005, 102: 12194-12199. 10.1073/pnas.0500925102.PubMedCentralCrossRefPubMed
69.
go back to reference Van Schaijk BC, Janse CJ, Van Gemert GJ, Van Dijk MR, Gego A, Franetich JF, van de Vegte-Bolmer M, Yalaoui S, Silvie O, Hoffman SL, Waters AP, Mazier D, Sauerwein RW, Khan SM: Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One. 2008, 3: e3549-10.1371/journal.pone.0003549.PubMedCentralCrossRefPubMed Van Schaijk BC, Janse CJ, Van Gemert GJ, Van Dijk MR, Gego A, Franetich JF, van de Vegte-Bolmer M, Yalaoui S, Silvie O, Hoffman SL, Waters AP, Mazier D, Sauerwein RW, Khan SM: Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One. 2008, 3: e3549-10.1371/journal.pone.0003549.PubMedCentralCrossRefPubMed
70.
go back to reference Hollingdale MR, Appiah A, Leland P, do Rosario VE, Mazier D, Pied S, Herrington DA, Chulay JD, Ballou WR, Derks T, Hiem Yap S, Beaudoin RL, Verhave JP: Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. Trans R Soc Trop Med Hyg. 1990, 84: 325-329. 10.1016/0035-9203(90)90303-V.CrossRefPubMed Hollingdale MR, Appiah A, Leland P, do Rosario VE, Mazier D, Pied S, Herrington DA, Chulay JD, Ballou WR, Derks T, Hiem Yap S, Beaudoin RL, Verhave JP: Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. Trans R Soc Trop Med Hyg. 1990, 84: 325-329. 10.1016/0035-9203(90)90303-V.CrossRefPubMed
71.
go back to reference Mota MM, Hafalla JC, Rodriguez A: Migration through host cells activates Plasmodium sporozoites for infection. Nat Med. 2002, 8: 1318-1322. 10.1038/nm785.CrossRefPubMed Mota MM, Hafalla JC, Rodriguez A: Migration through host cells activates Plasmodium sporozoites for infection. Nat Med. 2002, 8: 1318-1322. 10.1038/nm785.CrossRefPubMed
72.
go back to reference Renia L, Mattei D, Goma J, Pied S, Dubois P, Miltgen F, Nussler A, Matile H, Menegaux F, Gentilini M, Mazier D: A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol. 1990, 20: 1445-1449. 10.1002/eji.1830200706.CrossRefPubMed Renia L, Mattei D, Goma J, Pied S, Dubois P, Miltgen F, Nussler A, Matile H, Menegaux F, Gentilini M, Mazier D: A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol. 1990, 20: 1445-1449. 10.1002/eji.1830200706.CrossRefPubMed
73.
go back to reference Mazier D, Renia L, Nussler A, Pied S, Marussig M, Goma J, Grillot D, Miltgen F, Drapier JC, Corradin G, Del Giudice G, Grau GE: Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells. Immunol Lett. 1990, 25: 65-70. 10.1016/0165-2478(90)90093-6.CrossRefPubMed Mazier D, Renia L, Nussler A, Pied S, Marussig M, Goma J, Grillot D, Miltgen F, Drapier JC, Corradin G, Del Giudice G, Grau GE: Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells. Immunol Lett. 1990, 25: 65-70. 10.1016/0165-2478(90)90093-6.CrossRefPubMed
74.
go back to reference Dorshkind K, Keller GM, Phillips RA, Miller RG, Bosma GC, O'Toole M, Bosma MJ: Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol. 1984, 132: 1804-1808.PubMed Dorshkind K, Keller GM, Phillips RA, Miller RG, Bosma GC, O'Toole M, Bosma MJ: Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol. 1984, 132: 1804-1808.PubMed
75.
go back to reference Dorshkind K, Pollack SB, Bosma MJ, Phillips RA: Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol. 1985, 134: 3798-3801.PubMed Dorshkind K, Pollack SB, Bosma MJ, Phillips RA: Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol. 1985, 134: 3798-3801.PubMed
76.
go back to reference Graziano RF, Erbe DV, Fanger MW: The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements. J Immunol. 1989, 143: 3894-3900.PubMed Graziano RF, Erbe DV, Fanger MW: The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements. J Immunol. 1989, 143: 3894-3900.PubMed
77.
go back to reference Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA, Oloo JA, Blair PL, Aguiar JC, Baldi P, Davies DH, Felgner PL: Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics. 2008, 8: 4680-4694. 10.1002/pmic.200800194.PubMedCentralCrossRefPubMed Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA, Oloo JA, Blair PL, Aguiar JC, Baldi P, Davies DH, Felgner PL: Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics. 2008, 8: 4680-4694. 10.1002/pmic.200800194.PubMedCentralCrossRefPubMed
78.
go back to reference Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL: Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics. 2011, 10: M111 007948-10.1074/mcp.M111.007948.PubMedCentralCrossRefPubMed Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL: Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics. 2011, 10: M111 007948-10.1074/mcp.M111.007948.PubMedCentralCrossRefPubMed
Metadata
Title
Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum
Authors
Marije C Behet
Lander Foquet
Geert-Jan van Gemert
Else M Bijker
Philip Meuleman
Geert Leroux-Roels
Cornelus C Hermsen
Anja Scholzen
Robert W Sauerwein
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-136

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.